Three-Year Survival Following Multivessel Percutaneous Coronary Intervention With Bare-Metal or Drug-Eluting Stents in Unselected Patients

American Journal of Cardiology

Volumn 103, Issue 2, 2009, Pages 203-211

  Kukreja, Neville ^a   Onuma, Yoshinobu ^a   Garcia Garcia, Hector M ^a   Daemen, Joost ^a   van Domburg, Ron ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

'TAXUS'; CYPHER; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BARE METAL STENT; CONTROL GROUP; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; STENT THROMBOSIS; SURVIVAL;

CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; SIROLIMUS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58149458260     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.068     Document Type: Article

References (27)

1. Pocock S.J., Henderson R.A., Rickards A.F., Hampton J.R., King III S.B., Hamm C.W., Puel J., Hueb W., Goy J.J., and Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 346 (1995) 1184-1189
2. Mercado N., Wijns W., Serruys P.W., Sigwart U., Flather M.D., Stables R.H., O'Neill W.W., Rodriguez A., Lemos P.A., Hueb W.A., et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 130 (2005) 512-519
3. Serruys P.W., Ong A.T., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., Schonberger J.P., Buller N., Bonser R., Disco C., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
4. Bravata D.M., Gienger A.L., McDonald K.M., Sundaram V., Perez M.V., Varghese R., Kapoor J.R., Ardehali R., Owens D.K., and Hlatky M.A. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 147 (2007) 703-716
5. Serruys P., Daemen J., Morice M.C., De Bruyne B., Colombo A., Macaya C., Richardt G., Fajadet J., Hamm C., Dawkins K., et al. Three-year follow-up of the ARTS-II-sirolimus-eluting stents for the treatment of patients with multivessel disease. EuroInterv 3 (2007) 450-459
6. Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Vaina S., Morger C., Kukreja N., Juni P., Sianos G., Hellige G., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
7. Beohar N., Davidson C.J., Kip K.E., Goodreau L., Vlachos H.A., Meyers S.N., Benzuly K.H., Flaherty J.D., Ricciardi M.J., Bennett C.L., and Williams D.O. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
8. Win H.K., Caldera A.E., Maresh K., Lopez J., Rihal C.S., Parikh M.A., Granada J.F., Marulkar S., Nassif D., Cohen D.J., Kleiman N.S., and EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
9. Javaid A., Steinberg D.H., Buch A.N., Corso P.J., Boyce S.W., Pinto Slottow T.L., Roy P.K., Hill P., Okabe T., Torguson R., et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 116 (2007) I200-I206
10. Orlic D., Bonizzoni E., Stankovic G., Airoldi F., Chieffo A., Corvaja N., Sangiorgi G., Ferraro M., Briguori C., and Montorfano M. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol 43 (2004) 1154-1160
11. Mikhail G.W., Airoldi F., Tavano D., Chieffo A., Rogacka R., Carlino M., Montorfano M., Sangiorgi G., Corvaja N., Michev I., et al. The use of drug eluting stents in single and multivessel disease: results from a single centre experience. Heart 90 (2004) 990-994
12. Smith Jr. S.C., Dove J.T., Jacobs A.K., Kennedy J.W., Kereiakes D., Kern M.J., Kuntz R.E., Popma J.J., Schaff H.V., Williams D.O., et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 103 (2001) 3019-3041
13. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) e1-e121
14. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
15. Ong A.T., McFadden E.P., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
16. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.-A., Gabriel Steg P., Morel M.-a., Mauri L., Vranckx P., et al., Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
17. D'Agostino Jr. R.B. Propensity scores in cardiovascular research. Circulation 115 (2007) 2340-2343
18. Rodriguez A., Maree A., Grinfeld L., Fernandez-Pereira C., Mieres J., Alemparte M., Berrocal D., Rodriguez-Granillo G., Vigo C., Felsen M., O'Neill W., and Palacios I. Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial. EuroInterv 2 (2006) 53-60
19. King III S.B., Smith Jr. S.C., Hirshfeld Jr. J.W., Jacobs A.K., Morrison D.A., Williams D.O., Feldman T.E., Kern M.J., O'Neill W.W., Schaff H.V., et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 51 (2008) 172-209
20. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
21. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
22. Ong A.T.L., Serruys P.W., Mohr F.W., Morice M.-C., Kappetein A.P., Holmes J., David R., Mack M.J., van den Brand M., and Morel M.-A. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) Study: design, rationale, and run-in phase. Am Heart J 151 (2006) 1194-1204
23. Detre K.M., Guo P., Holubkov R., Califf R.M., Sopko G., Bach R., Brooks M.M., Bourassa M.G., Shemin R.J., Rosen A.D., et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99 (1999) 633-640
24. Kapur A., Malik I.S., Bagger J.P., Anderson J.R., Kooner J.S., Thomas M., Punjabi P., Mayet J., Millane T., Goedicke J., et al. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am Heart J 149 (2005) 13-19
25. Farkouh M.E., Dangas G., Leon M.B., Smith C., Nesto R., Buse J.B., Cohen D.J., Mahoney E., Sleeper L., King III S., et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J 155 (2008) 215-223
26. Hannan E.L., Wu C., Walford G., Culliford A.T., Gold J.P., Smith C.R., Higgins R.S.D., Carlson R.E., and Jones R.H. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358 (2008) 331-341
27. Hordijk-Trion M., Lenzen M., Wijns W., de Jaegere P., Simoons M.L., Scholte op Reimer W.J., Bertrand M.E., Mercado N., and Boersma E. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J 27 (2006) 671-678